IL6 and PFAPA syndrome: Previous therapeutic strategies for autoinflammatory diseases such as PFAPA have primarily relied on findings from retrospective studies and the expertise of physicians, including colchicine, nonsteroidal anti‐inflammatory drugs (NSAIDs), glucocorticoids, IL‐1 blockers, anti‐TNF agents, anti‐IL‐6 agents, and Janus kinase (JAK) inhibitors [14, 19].